A novel vascular smooth muscle chymase is upregulated in hypertensive rats

Caiying Guo, Haisong Ju, Debbie Leung, Hamid Massaeli, Mingda Shi, Marlene Rabinovitch

Research output: Contribution to journalArticle

83 Citations (Scopus)


While greater than 80% of angiotensin II (Ang II) formation in the human heart and greater than 60% in arteries appears to result from chymase activity, no cardiovascular cell-expressed chymase has been previously reported. We now describe the cloning of a full-length cDNA encoding a novel chymase from rat vascular smooth muscle cells. The cDNA encompasses 953 nucleotides, encodes 247 amino acids, and exhibits 74% and 80% homology in amino acid sequence to rat mast cell chymase I and II, respectively. Southern blot analysis indicates that the rat vascular chymase is encoded by a separate gene. This chymase was induced in hypertrophied rat pulmonary arteries, with 11-fold and 8-fold higher chymase mRNA levels in aortic and pulmonary artery smooth muscle cells from spontaneously hypertensive than in corresponding tissues from normotensive rats. We assayed the activity of the endogenous enzyme and of a recombinant, epitope-tagged chymase in transfected smooth muscle cells and showed that Ang II production from Ang I can be inhibited with chymostatin, but not EDTA or captopril. Spontaneously hypertensive rats show elevated chymase expression and increased chymostatin-inhibitable angiotensin-converting activity, suggesting a possible role for this novel enzyme in the pathophysiology of hypertension.

Original languageEnglish
Pages (from-to)703-715
Number of pages13
JournalJournal of Clinical Investigation
Issue number6
Publication statusPublished - 1 Jan 2001
Externally publishedYes


ASJC Scopus subject areas

  • Medicine(all)

Cite this